Napoli Bern Ripka Law Firm

Plaintiffs' Personal Injury Law Firm

Tysabri

Tysabri is used as a last chance treatment for Multiple Sclerosis, and has rather controversial from the first implementation in 2004. Tysabri is manufactured by Biogen Idec Inc. and Elan Corp and was taken off of the market twice since first appearing on the market. The first removal of Tysabri occurred in 2005 when the drug was linked to causing a fatal brain infection. However in 2006, the FDA deemed that the drug's benefits outweighed the associate risks with treating Crohn's disease. This was another controversial decision as many medical professionals and studies done showed the effects associated with taking the drug.

Shockingly in 2008, the manufacturers of Tysabri sent a letter out to the FDA warning that Tysabri had causes severe liver complications in some of their patients. There was much upheaval and discussion as to what should be done with Tysabri. Finally a decision was made and warnings were put on labels of Tysabri as to the possible liver damage associated with taking the drug. However Tysabri remains on the market to aid with Crohn's disease.

Many medical professionals are still very skeptical as to why Tysabri is still on the market even though it has show to incur severe complications with the liver. Consumers who used the product in the beginning stages of the products lifecycle have more of a threat to contract PML, a fatal brain disorder. The second stage of the products lifestyle was more apt to affect the liver.

If you have taken Tysabri between these years and have shown symptoms of liver failure or brain infection, this might have occurred due to taking Tysabri. Our super lawyers at Napoli Bern Ripka, LLP have tremendous experience in dealing with prescription drugs and their associated pharmaceutical companies and manufacturers. If you have fallen victim to Tysabri, contact us today and we will get you on the path to justice.

Personal Injury

Medical Malpractice